LAUSR

ABSTRACT Stroke results in enduring damage to the brain which is accompanied by innate neurorestorative processes, such as reorganization of surviving circuits. Nevertheless, patients are often left with permanent residual impairments. Cell based therapy is an emerging therapeutic that may function to enhance the innate neurorestorative capacity of the brain. We previously evaluated human umbilical tissue‐derived cells (hUTC) in our non‐human primate model of cortical injury limited to the hand area of primary motor cortex. Injection of hUTC 24h after injury resulted in significantly enhanced recovery of fine motor function compared to vehicle treated controls (Moore et al., 2013). These monkeys also received an injection of Bromodeoxyuridine (BrdU) 8days after cortical injury to label cells undergoing replication. This was followed by 12weeks of behavioral testing, which culminated 3h prior to perfusion in a final behavioral testing session using only the impaired hand. In this session, the neuronal activity initiating hand movements leads to the upregulation of the immediate early gene c‐Fos in activated cells. Following perfusion‐fixation of the brain, sections were processed using immunohistochemistry to label c‐Fos activated cells, pre‐synaptic vesicle protein synaptophysin, and BrdU labeled neuroprogenitor cells to investigate the hypothesis that hUTC treatment enhanced behavioral recovery by facilitating reorganization of surviving cortical tissues. Quantitative analysis revealed that c‐Fos activated cells were significantly increased in the ipsi‐ and contra‐lesional ventral premotor but not the dorsal premotor cortices in the hUTC treated monkeys compared to placebo controls. Furthermore, the increase in c‐Fos activated cells in the ipsi‐ and contra‐lesional ventral premotor cortex correlated with a decrease in recovery time and improved grasp topography. Interestingly, there was no difference between treatment groups in the number of synaptophysin positive puncta in either ipsi‐ or contra‐lesional ventral or dorsal premotor cortices. Nor was there a significant difference in the density of BrdU labeled cells in the subgranular zone of the hippocampus or the subventricular zone of the lateral ventricle. These findings support the hypothesis that hUTC treatment enhances the capacity of the brain to reorganize after cortical injury and that bilateral plasticity in ventral premotor cortex is a critical locus for this recovery of function. This reorganization may be accomplished through enhanced activation of pre‐existing circuits within ventral premotor, but it could also reflect ventral premotor projections to the brainstem or spinal cord. HIGHLIGHTSc‐Fos activation increases with hUTC treatment in PMv but not PMd after M1 injury.c‐Fos activation is positively associated with improved recovery after M1 injury.Density of synaptophysin in PM does not differ with hUTC treatment after M1 injury.